EphB2 signaling-mediated Sirt3 expression reduces MSC senescence by maintaining mitochondrial ROS homeostasis
Young Hyun Jung1, Hyun Jik Lee1, Jun Sung Kim1
1Department of Veterinary Physiology, College of Veterinary Medicine, Research Institute for Veterinary Science, and BK21 PLUS Program for Creative Veterinary Science Research Center, Seoul National University, Seoul 08826, Republic of Korea.
Abstract:
Disruption of mitochondrial reactive oxygen species (mtROS) homeostasis is a key factor inducing UCB-MSC senescence. Accordingly, preventing mtROS accumulation will help in suppressing the UCB-MSC senescence. In this study, we observed that the expressions of EphrinB2 and EphB2 were inversely regulated by UCB-MSC passage-dependent manner. EphB2 signaling induced mitochondrial translocation of Sirt3. The knockdown of SIRT3 inhibited the effect of EphB2 signaling in UCB-MSCs. Subsequently, EphrinB2-Fc induced the nuclear translocation of Nrf-2 via c-Src phosphorylation dependent manner, and Sirt3 expression was regulated by Nrf-2. Among Sirt3 target genes, EphB2 signaling increased MnSOD and reduced the mtROS level in UCB-MSCs. Furthermore, the deacetylase effect of Sirt3 enhanced the MnSOD activity by deacetylation at the lysine 68 residue and therapeutic effect of UCB-MSCs on skin-wound healing was increased by EphB2 activation. In conclusion, the EphB2 can serve as a novel target for the optimizing the therapeutic use of UCB-MSCs in wound repair by MnSOD-mediated mtROS scavenging through EphB2/c-Src signaling pathway and Nrf-2-dependent Sirt3 expression.
Insights
Activating EphB2 signaling in umbilical cord-derived mesenchymal stem cells (UCB-MSCs) reduces mitochondrial reactive oxygen species (mtROS) and enhances wound healing. This occurs via Nrf-2-dependent Sirt3 expression, boosting MnSOD activity.
Area of Science:
- Stem Cell Biology
- Mitochondrial Biology
- Wound Healing Research
Background:
- Mitochondrial reactive oxygen species (mtROS) homeostasis disruption drives UCB-MSC senescence.
- Preventing mtROS accumulation is crucial for suppressing UCB-MSC senescence.
Purpose of the Study:
- To investigate the role of EphB2 signaling in UCB-MSC senescence and therapeutic potential.
- To elucidate the molecular mechanisms linking EphB2, Sirt3, and mtROS regulation.
Main Methods:
- Studied EphrinB2/EphB2 expression in UCB-MSCs during passaging.
- Investigated EphB2-induced Sirt3 mitochondrial translocation and Nrf-2 nuclear translocation.
- Assessed MnSOD activity and mtROS levels following EphB2 activation.
- Evaluated the therapeutic effect of UCB-MSCs in skin-wound healing models.
Main Results:
- EphB2 signaling induced Sirt3 mitochondrial translocation, dependent on SIRT3.
- EphrinB2-Fc treatment promoted Nrf-2 nuclear translocation via c-Src phosphorylation, regulating Sirt3.
- EphB2 signaling increased MnSOD and reduced mtROS by Sirt3-mediated deacetylation of MnSOD.
- EphB2 activation enhanced UCB-MSC therapeutic efficacy in skin-wound healing.
Conclusions:
- EphB2 activation optimizes UCB-MSC therapeutic use in wound repair.
- The mechanism involves MnSOD-mediated mtROS scavenging via the EphB2/c-Src/Nrf-2/Sirt3 pathway.
- EphB2 represents a novel therapeutic target for enhancing UCB-MSC functions.
Related Concept Videos
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Mitochondria
PI3K/mTOR/AKT Signaling Pathway
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...

